Vimla Windlass News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Windlas Biotech raises over Rs 120 crore from anchor investors ahead of IPO The company has decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according to a circular uploaded on BSE website The Initial Public Offer (IPO) comprises fresh issuance of equity shares worth Rs 165 crore (Source: PTI) PTI Updated Aug 04, 2021, 1:18 PM IST Windlas Biotech, a manufacturer of pharmaceutical formulations, on Tuesday said it has raised over Rs 120 crore from anchor investors ahead of its IPO that opens on Wednesday. The company has decided to ...

4 IPOs open on Aug 4: Krsnaa Diagnostics, Windlas Biotech, Devyani International and Exxar Tiles Four IPOs will open for subscription on Wednesday (August 4). These include initial public offerings (IPOs) of Windlas Biotech, Devyani International, Krsnaa Diagnostics and Exxaro Tiles. Buoyed by bumper listings of Clean Science and Technology, GR Infraprojects, Zomato and Tatva Chintan Pharma Chem on the bourses, the four firms are expecting for their turn to make a strong debut on the Dalal Street. Let's take a look at four IPOs that will open for subscription this week:  Krsnaa Diagnostics...

Windlas Biotech IPO opens on Aug 4, price band fixed at Rs 448-460 SECTIONS Share Synopsis Windlas Biotech will raise Rs 165 crore through the issuance of fresh equity shares, while promoters and existing shareholders will offload 51,42,067 equity shares via an offer-for-sale (OFS). iStock New Delhi: The initial public offering (IPO) of Windlas Biotech will hit the primary market on August 4. The price band for the same has been fixed at Rs 448-460 per share with a face value of Rs 5 each. Dehradun-based Windlas Biotech is one of the top companies in the domestic pharmaceutical formulations c...